Initial studies have shown that individuals with BRCA1 or BRCA2 mutations were 84% more susceptible to breast cancer and 40% more susceptible to ovarian cancer throughout their lifetime 30-32. This evidence concerns the gene BRCA2 and ovarian cancer.